SCHEMBL30633149

SCHEMBL30633149

CCCCN(CC)CCNC(=O)c1cc2c(-c3ccc4[nH]nc(N)c4c3)ccnc2[nH]1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ NUDT1 P36639 5/20 0.45
▸ CCNK O75909 2/20 0.42
▸ CDK12 Q9NYV4 2/20 0.42
▸ DYRK1A Q13627 4/20 0.41
▸ WNT1 P04628 3/20 0.41
▸ CHUK O15111 2/20 0.41
▸ INSR P06213 2/20 0.41
▸ MAPK8 P45983 2/20 0.41
▸ CAMKK2 Q96RR4 2/20 0.41
▸ MEN1 O00255 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ AURKA O14965 3/20 0.39
▸ AURKB Q96GD4 3/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ TP53 P04637 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ RAD52 P43351 1/20 0.38
▸ JAK2 O60674 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26685975 1.00 NUDT1 (0.45) NUDT1CCNKCDK12DYRK1AWNT1
SCHEMBL26686576 0.87 CCNK (0.55) NUDT1CCNKCDK12DYRK1AWNT1
SCHEMBL30633128 0.87 CCNK (0.55) NUDT1CCNKCDK12DYRK1AWNT1
SCHEMBL26685911 0.85 CHUK (0.56) NUDT1CCNKCDK12DYRK1AWNT1
SCHEMBL30633157 0.85 CHUK (0.56) NUDT1CCNKCDK12DYRK1AWNT1
SCHEMBL26686470 0.85 NUDT1 (0.46) NUDT1CCNKCDK12DYRK1AWNT1
SCHEMBL30633154 0.85 NUDT1 (0.46) NUDT1CCNKCDK12DYRK1AWNT1
SCHEMBL31240736 0.84 NUDT1 (0.49) NUDT1CCNKCDK12DYRK1AWNT1
SCHEMBL26685908 0.84 NUDT1 (0.49) NUDT1CCNKCDK12DYRK1AWNT1
SCHEMBL31240633 0.83 CCNK (0.54) NUDT1CCNKCDK12DYRK1AWNT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4705291-A1 IKK-ALPHA INHIBITORS Cancer Research Technology Limited (GB) 2026-03-11 — — EP claimed
EP-4522597-A1 IKK INHIBITORS Cancer Research Technology Limited (GB) 2025-03-19 — — EP claimed
WO-2024228035-A1 IKK-ALPHA INHIBITORS CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2024-11-07 — — WO claimed
WO-2023218201-A1 IKK INHIBITORS CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2023-11-16 — — WO claimed
EP-4705291-A1 IKK-ALPHA INHIBITORS Cancer Research Technology Limited (GB) 2026-03-11 — — EP disclosed
EP-4522597-A1 IKK INHIBITORS Cancer Research Technology Limited (GB) 2025-03-19 — — EP disclosed
WO-2024228035-A1 IKK-ALPHA INHIBITORS CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2024-11-07 — — WO disclosed
WO-2023218201-A1 IKK INHIBITORS CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2023-11-16 — — WO disclosed
Send feedback